Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 9, 2019Current Opinion in Neurology

Neurochemical biomarkers in amyotrophic lateral sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

FVFederico VerdeIRCCS Istituto Auxologico ItalianoVSVincenzo SilaniUniversity of MilanMOMarkus OttoUniversity of Kassel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Verde et al. (2019) studied this question.

synapsesocial.com/papers/6a92a576363ee85fa149fcd7https://doi.org/10.1097/wco.0000000000000744
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis2013 · 111 citations
  2. 2Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study2016 · 46 citations
  3. 3Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases2013 · 496 citations
  4. 4Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net2016 · 94 citations